Literature DB >> 22796043

Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.

Mónica S Estevão1, Luísa C R Carvalho, Marisa Freitas, Ana Gomes, Aldino Viegas, João Manso, Stefan Erhardt, Eduarda Fernandes, Eurico J Cabrita, M Manuel B Marques.   

Abstract

The close structural similarity between the two cyclooxygenase (COXs) isoforms and the absence of selective inhibitors without side effects continues to stimulate the development of novel approaches towards selective anti-inflammatory drugs. In the present study a small library of new indolic compounds involving two different substitutions patterns at the indole scaffold was synthesized. In order to establish a relation between the spatial distribution of known functional groups related with inhibitory activity, two substitution patterns were explored: one with substituents at N-1, C-3, C-5 positions and another at C-2, C-3 and C5 positions. Accordingly, indole positions C-5, C-3 and N-1 were substituted with: sulfonamide or methylsulfone at C-5, p-halo-benzyl group at C-3, and an alkyl chain with a trifluoromethyl group at N-1. Alternatively, a p-halo-benzyl group was introduced at C-2, leaving the indolic nitrogen free. Inhibitory studies were performed and the activity results obtained against both COXs isoforms were rationalized based on docking and NMR studies. Docking studies show that dialkyation at C-2 and C-3 favors a binding with an orientation similar to that of the known selective inhibitor SC-558. From the tested compounds, this substitution pattern is correlated with the highest inhibitory activity and selectivity: 70% COX-2 inhibition at 50 μM, and low COX-1 inhibition (18 ± 9%). Additionally, Saturation Transfer Difference NMR experiments reveal different interaction patterns with both COXs isoforms that may be related with different orientations of the sulfonamide group in the binding pocket. Despite the moderated inhibitory activities found, this study represents an innovative approach towards COXs inhibitory activity rationalization and to the design of anti-inflammatory drugs.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796043     DOI: 10.1016/j.ejmech.2012.06.040

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Chlorinated Flavonoids Modulate the Inflammatory Process in Human Blood.

Authors:  Carina Proença; Daniela Ribeiro; Tânia Soares; Sara M Tomé; Artur M S Silva; José L F C Lima; Eduarda Fernandes; Marisa Freitas
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

2.  Synthesis of N-arylmethyl Substituted Indole Derivatives as New Antiplatelet Aggregation Agents.

Authors:  Masoud Faghih Akhlaghi; Salimeh Amidi; Marjan Esfahanizadeh; Marjan Daeihamed; Farzad Kobarfard
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 3.  Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.

Authors:  Markus Laube; Torsten Kniess; Jens Pietzsch
Journal:  Antioxidants (Basel)       Date:  2016-04-19

Review 4.  Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years.

Authors:  Zhiran Ju; Menglan Li; Junde Xu; Daniel C Howell; Zhiyun Li; Fen-Er Chen
Journal:  Acta Pharm Sin B       Date:  2022-01-11       Impact factor: 14.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.